Low-dose rapamycin is antiangiogenic in Ewing sarcoma via a VEGF-independent pathway
Aaron M. Lipskar, Richard D. Glick, Jianzhong Huang, Morris Edelman, James DeVoti, Raymond Pica, Bettie M. Steinberg, Samuel Z. SofferVolume:
209
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/j.jamcollsurg.2009.06.157
File:
PDF, 92 KB
english, 2009